UK Extends VPAG Opt-Out Deadline Amid Global Pharma Uncertainty

 
• By Eliza Slawther
  
A four-week extension to the VPAG opt-out deadline for 2026 has been agreed (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access